Clinical trial
Rituximab and Combination Chemotherapy in Treating Older Patients With…
NCT00290667 · German High-Grade Non-Hodgkin's Lymphoma Study Group, Other · Completed
Key facts
| NCT number | NCT00290667 |
|---|---|
| Title | Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma |
| Official title | 2-Weekly CHOP Chemotherapy With Dose-Dense Rituximab for the Treatment of Patients Aged 61 to 80 Years With Aggressive CD-20 Positive B-Cell Lymphomas: A Phase-II/Pharmacokinetic Study (CHOP-R-ESC) |
| Lead sponsor | German High-Grade Non-Hodgkin's Lymphoma Study Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Other, Radiation |
| Interventions | pegfilgrastim, rituximab, cyclophosphamide, doxorubicin hydrochloride, prednisone, vincristine sulfate, pharmacological study, radiation therapy |
| Enrollment | 586 |
| Start date | Feb 1, 2004 |
| Primary completion | Dec 1, 2013 |
| Completion | Nov 1, 2015 |
| First posted | Feb 13, 2006 |
| Last update posted | May 18, 2021 |
| Countries | Czechia, France, Germany, Italy, Netherlands, Poland, Sweden, Switzerland, United Kingdom |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: